Month: April 2022

Alpha Metaverse Technologies Announces Signing of Definitive Agreement to Acquire 100% of Shape Immersive Entertainment Inc.

Written by Customer Service on April 13, 2022. Posted in Mergers And Acquisitions.

VANCOUVER, British Columbia, April 13, 2022 (GLOBE NEWSWIRE) — Alpha Metaverse Technologies Inc. (CSE: ALPA) (FSE: 9HN0), (OTC PINK: APETF) (“Alpha” or the “Company”) is pleased to announce, further to the Company’s news release dated January 24, 2022, that it has signed a definitive agreement (the “Agreement”) with Shape Immersive Entertainment Inc. (“Shape”) and all of the shareholders of Shape (the “Shape Shareholders”), to acquire (the “Acquisition”) 100% of the issued and outstanding share capital of Shape. Upon completion of the Acquisition, Shape will continue to function as a fully operational metaverse creator engaged in the development of non-fungible token (“NFT”) technology, augmented reality experiences, and three dimensional (“3D”) products to transform user experiences. Shape is a leader in 3D NFTs, holograms, augmented...

Terra Firma Capital Corporation Reports Fourth Quarter & Full Year 2021 Financial Results

Written by Customer Service on April 13, 2022. Posted in Earnings Releases And Operating Results.

All amounts are stated in United States dollars unless otherwise indicated. TORONTO, April 13, 2022 (GLOBE NEWSWIRE) — Terra Firma Capital Corporation (TSX-V: TII) (“Terra Firma” or the “Company“), a real estate finance company, today announced its financial results for the three months and year ended December 31, 2021. Full Year 2021 Financial Highlights:Total Assets of $139.3 million Total Investments (a non-IFRS financial measure)(1) of $115.3 million. Total Assets under management (“AUM,” a non-IFRS financial measure)(4) of $128.5 million and unfunded commitments of $119.1 million Book Value per share increased to $7.83 (CA$9.83(3)) per share CA$0.21 per share paid in dividends Total revenue increased by 5.0% to $16.2 million Net income and comprehensive income increased by 54.0% to $3.3...

Shaw Announces Second Quarter and Year-to-Date Fiscal 2022 Results

Written by Customer Service on April 13, 2022. Posted in Earnings Releases And Operating Results.

Second quarter consolidated financial results include adjusted EBITDA1 of $632 million along with free cash flow1 of $217 million The Company continues to focus on balancing growth and profitability while investing in our networks and delivering better customer experiences Key regulatory approval for the combination of Rogers and Shaw obtainedCALGARY, Alberta, April 13, 2022 (GLOBE NEWSWIRE) — Shaw Communications Inc. (“Shaw” or the “Company”) announces consolidated financial and operating results for the quarter ended February 28, 2022. On a year-over-year basis, consolidated revenue decreased by 2.0% to $1.36 billion, adjusted EBITDA decreased 0.8% to $632 million and net income decreased 9.7% to $196 million. Throughout the second quarter, which experienced the peak of the omicron variant of COVID-19 across Canada, the...

EMCORE Awarded Medallion 8100 L-EML™ Transmitter Contract Extension for Multi-Year Project in Europe

Written by Customer Service on April 13, 2022. Posted in Public Companies.

ALHAMBRA, Calif., April 13, 2022 (GLOBE NEWSWIRE) — EMCORE Corporation (Nasdaq: EMKR), a leading provider of advanced mixed-signal products that serve the aerospace & defense, communications, and sensing markets, announced today that it has been awarded a contract extension for Medallion 8100 Series L-EMLTM CATV transmitters by a major broadband MSO in Europe. This contract extension brings the value of L-EML transmitters shipped for this multi-year project to over $2 million. For this phase of the project, EMCORE expects to deliver transmitters beginning in the 2nd calendar quarter of 2022. EMCORE’s breakthrough L-EML transmitter technology was launched at ANGACOM in 2016 and entered volume production in 2017, successfully achieving wide market acceptance. The Medallion 8100 Series L-EML rackmount transmitters being shipped...

Artelo Biosciences Reports Positive Pre-clinical Results for Lead Program in Cancer-Related Cachexia

Written by Customer Service on April 13, 2022. Posted in Public Companies.

New Research from Trinity College Dublin Indicates Broader Therapeutic Potential for ART27.13 SOLANA BEACH, Calif., April 13, 2022 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and neurological conditions, today announced that ART27.13, a peripherally selective G-Protein Coupled Receptor (GPCR) full agonist currently in clinical development for cancer-related anorexia, shows promising pre-clinical results in protecting human muscle cells from cancer-induced muscle degeneration (cachexia) via a CB2 mediated mechanism of action. “These are very encouraging data for two important reasons,” said Richard Porter, Ph.D., of the School of Biochemistry & Immunology at Trinity...

Nuvectis Pharma Recaps Poster Presentation Highlights for NXP900 at the 2022 American Association for Cancer Research (AACR) Conference

Written by Customer Service on April 13, 2022. Posted in Public Companies.

Fort Lee, NJ, April 13, 2022 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc (NASDAQ: NVCT), (“Nuvectis” or the “Company”), a biopharmaceutical company focused on the development of precision medicines for serious conditions of unmet medical need in oncology, today provided highlights from the poster presentation of NXP900 that took place yesterday at the American Association for Cancer Research (“AACR”) Conference in New Orleans. “A growing body of scientific evidence provides exciting development opportunities for NXP900″ said Ron Bentsur, Chairman and Chief Executive Officer of Nuvectis. “NXP900 is a very potent and selective SRC/YES1 inhibitor with a unique mechanism of action that inhibits both the catalytic and scaffolding functions of the target kinases. Yesterday’s poster presentation demonstrated for the first time the potency...

Isracann Biosciences Acquires Natural Health Medicine Developer and Appoints Natural Health Products Officers

Written by Customer Service on April 13, 2022. Posted in Mergers And Acquisitions.

VANCOUVER, British Columbia, April 13, 2022 (GLOBE NEWSWIRE) — Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) is pleased to announce that, further to the Company’s news releases dated February 23, 2022 and March 28, 2022, it has closed its acquisition of Praesidio Health Inc. (“Praesidio”). Pursuant to the definitive agreement dated March 24, 2022 with Praesidio and the shareholders of Praesidio (the “Praesidio Shareholders”), the Company acquired all of the issued and outstanding shares in the capital of Praesidio (the “Praesidio Shares”) for aggregate consideration of C$4,000,000 in common shares (the “Consideration Shares”) in the capital of the Company (the “Transaction”). Praesidio will operate as a wholly-owned subsidiary of the Company. Praesidio (https://www.praesidiohealth.com/) is an...

Emergia Inc. Announces Closing of a Private Placement of Convertible Debentures and Units

Written by Customer Service on April 13, 2022. Posted in Public Companies.

MONTREAL, April 13, 2022 (GLOBE NEWSWIRE) — (CSE: EMER) Emergia Inc. (the “Corporation or “Emergia”) is pleased to announce that it has completed a closing of a private placement for a total amount of $1,305,000 in cash, composed of $705,000 of convertible debentures (the “Debentures”) and $600,000 in units (the “Units”) of the Corporation at a price of $0.80 per Unit. The Debentures bear interest at the rate of 8% per year, accruing in arrears, payable semi-annually in cash or in Class A Common Shares (the “Shares”) of the Corporation. The Debentures are convertible at the holder’s option into one unit (the “Debentures Units”) of the Corporation at a conversion price of $0.90. Each Debenture Unit is composed of one Share in the capital of the Corporation and two (2) warrants of the Corporation: (i) a warrant of the Corporation...

EV Technology Group Commences Construction on Moke Flagship – Set to Open in Summer 2022

Written by Customer Service on April 13, 2022. Posted in Public Companies.

Casa Moke – 3D views (non-final) Casa Moke – 3D views (non-final)Casa Moke – 3D views (non-final) Casa Moke – 3D views (non-final)ST TROPEZ, France, April 13, 2022 (GLOBE NEWSWIRE) — EV Technology Group Ltd.’s wholly owned subsidiary, Moke France SAS, announces today that it has commenced construction on a Moke flagship store in St Tropez, France. The construction of this flagship fits with EV Technology Group’s strategy of electrifying iconic brands: carefully selecting legendary cars and bringing them forward with an electric twist. Moke, the heritage car created by Austin Mini’s designer, Sir Alec Issogonis, began its rise to cult status in the 1960’s when the likes of Brigitte Bardot and Alain Delon drove it along the French Riviera coastline. “Saint-Tropez has a strong resonance in the worldwide...

Texas City Joins Growing List of Municipalities Securing Access to Sensitive Data with BIO-key’s PortalGuard Identity and Access Management Platform

Written by Customer Service on April 13, 2022. Posted in Public Companies.

DALLAS and WALL, N.J., April 13, 2022 (GLOBE NEWSWIRE) — BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB), today announced that a Texas city has selected its PortalGuard IAM platform, with support for a broad array of multi-factor authentication (MFA) options, to protect its enterprise applications and data. Leveraging the PortalGuard IAM platform, the municipality can strengthen its overall security posture and effectively respond to evolving cyber threats. This new customer relationship, BIO-key’s first with a Texas municipality, was secured by Dallas-based IT consulting firm Mejeticks through BIO-key’s master agent Intelisys. Cyber-attacks against municipalities have increased significantly in...

Month: April 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals